Artiva slumps after discontinuing lead asset

Artiva Biotherapeutics (ARTV) stock plunged after fatal trial events prompted the company to discontnue its lead canddiate AlloNK and layoff staff. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real